277 related articles for article (PubMed ID: 17979706)
1. Targeting epigenetic modifiers in cancer.
Holloway AF; Oakford PC
Curr Med Chem; 2007; 14(24):2540-7. PubMed ID: 17979706
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
3. Targeting DNA methylation in cancer.
Szyf M
Bull Cancer; 2006 Sep; 93(9):961-72. PubMed ID: 16980240
[TBL] [Abstract][Full Text] [Related]
4. Review-Epigenetic therapy for cancer.
Saleem M; Abbas K; Manan M; Ijaz H; Ahmed B; Ali M; Hanif M; Farooqi AA; Qadir MI
Pak J Pharm Sci; 2015 May; 28(3):1023-32. PubMed ID: 26004710
[TBL] [Abstract][Full Text] [Related]
5. Reversing aberrant methylation patterns in cancer.
Poke FS; Qadi A; Holloway AF
Curr Med Chem; 2010; 17(13):1246-54. PubMed ID: 20166939
[TBL] [Abstract][Full Text] [Related]
6. Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies.
Salarinia R; Sahebkar A; Peyvandi M; Mirzaei HR; Jaafari MR; Riahi MM; Ebrahimnejad H; Nahand JS; Hadjati J; Asrami MO; Fadaei S; Salehi R; Mirzaei H
Curr Cancer Drug Targets; 2016; 16(9):773-788. PubMed ID: 26638884
[TBL] [Abstract][Full Text] [Related]
7. Interplay between different epigenetic modifications and mechanisms.
Murr R
Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics, disease, and therapeutic interventions.
Lu Q; Qiu X; Hu N; Wen H; Su Y; Richardson BC
Ageing Res Rev; 2006 Nov; 5(4):449-67. PubMed ID: 16965942
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic small molecule modulators of histone and DNA methylation.
Hauser AT; Robaa D; Jung M
Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
[TBL] [Abstract][Full Text] [Related]
10. [DNA methylation and cancer].
Yoshikawa H
Gan To Kagaku Ryoho; 2007 Feb; 34(2):145-9. PubMed ID: 17301518
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic therapy--a new development in pharmacology.
Peedicayil J
Indian J Med Res; 2006 Jan; 123(1):17-24. PubMed ID: 16567863
[TBL] [Abstract][Full Text] [Related]
12. Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications.
Silverman BR; Shi J
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999365
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic drugs that do not target enzyme activity.
Owen DR; Trzupek JD
Drug Discov Today Technol; 2014 Jun; 12():e29-34. PubMed ID: 25027371
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic gene regulation in cancer.
Ballestar E; Esteller M
Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies.
Bhalla KN
J Clin Oncol; 2005 Jun; 23(17):3971-93. PubMed ID: 15897549
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation: a new research area for melatonin?
Korkmaz A; Reiter RJ
J Pineal Res; 2008 Jan; 44(1):41-4. PubMed ID: 18078446
[TBL] [Abstract][Full Text] [Related]
17. Histone modifications and cancer.
Sawan C; Herceg Z
Adv Genet; 2010; 70():57-85. PubMed ID: 20920745
[TBL] [Abstract][Full Text] [Related]
18. Dietary components impact histone modifications and cancer risk.
Davis CD; Ross SA
Nutr Rev; 2007 Feb; 65(2):88-94. PubMed ID: 17345961
[TBL] [Abstract][Full Text] [Related]
19. Deregulation of epigenetic mechanisms in cancer.
Maleszewska M; Wojtas B; Kamińska B
Postepy Biochem; 2018 Oct; 64(2):148-156. PubMed ID: 30656897
[TBL] [Abstract][Full Text] [Related]
20. DNA methylomes, histone codes and miRNAs: tying it all together.
Guil S; Esteller M
Int J Biochem Cell Biol; 2009 Jan; 41(1):87-95. PubMed ID: 18834952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
